New medication--nefazodone.Reports on Bristol-Myers Squibb Pharmaceuticals' market release of a serotonin selective uptake inhibitor called nefazodone (Serzone). Study published in the 'Journal of Clinical Psychiatry' which suggests that nefazodone is well-tolerated and effective for depression....
According to the U.S. Food and Drug Administration (FDA), a prescription medicine, which has already been approved for pain management, has been approved in a new medication formulation. The product is called Belbuca and it is a buprenorphine buccal film product (dissolvable medication) that pro...
2025 Medication for Opioid Use Disorder in Federally Qualified Health Centers JAMA Network Open Research January 16, 2025 Select Your Interests View Correction This Issue Views 69,699 Citations 1,507 1605 Download PDF More Cite This Permissions Original Investigation June 21, 2017 New Persistent Opioi...
A new study finds that combining music therapy(疗法) with a standard treatment for depression-medication,plus psychotherapy and counseling (辅导)-improves patient outcomes.Researchers invited 79people between the ages of 18and 50years old who had been diagnosed with depression.33of the participants we...
These could be additional targets for new drugs.This discovery not only brings new hope to the 40 per cent or so of patients with depression who don't respond to medication, but to many others who only experience relief after months and sometimes years of treatment.The researchers also noted...
Clinicians should be aware of predictors of new sleep medication and treatment users and discuss various forms of treatment or behavioral changes to help patients best manage sleep disturbance. 展开 关键词: Depression Medication Sleep DOI: 10.1093/gerona/glv227 被引量: 8 ...
(GABA-Cl) channel specific to insects. The S-enantiomer is the active component in the drug product which is the first-in-class medication for this ocular disease. Twice-daily treatment with lotilaner ophthalmic solution has demonstrated significant reduction in collarettes in the upper eyelid ...
(BMI) between 18.5 and 24.9 kg/m2, in good general health (i.e. without any chronic pathology and not taking any medication at the time of inclusion and/or on a long-term basis), able and willing to participate in the research by complying with the protocol, affiliated to a social ...
Long-acting buprenorphine formulations have been recently marketed for the Opioid Agonist Treatment (OAT) of opioid use disorder (OUD) associated with medical, social, and psychological support. Their duration of action ranges from one week up to 6 months. The non-medical use of opioids is increa...
The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: A meta-analysis. Acta Psychiatr. Scand. 2010, 121, 415–423. [Google Scholar] [CrossRef] [PubMed] Brakemeier, E.-L.; Köhler, S.; Sterzer, P. Schulenübergreifende Psycho...